First Hawaiian Bank’s Jazz Pharmaceuticals JAZZ Stock Holding History

First Hawaiian Bank’s Portfolio JAZZ Stock Details JAZZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-3,356	Closed	-$501K	–	809
2019 Q4	$501K	Buy	3,356 +348	+12%	+$47.4K	0.02%	471
2019 Q3	$386K	Sell	3,008 -1,232	-29%	-$165K	0.02%	557
2019 Q2	$604K	Buy	4,240 +3,458	+442%	+$465K	0.03%	391
2019 Q1	$112K	Buy	782 +462	+144%	+$60.3K	0.01%	871
2018 Q4	$39K	Buy	320 +95	+42%	+$14.1K	﹤0.01%	1139
2018 Q3	$38K	Buy	+225	New	+$38.7K	﹤0.01%	1226

Other funds holding JAZZ

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

First Hawaiian Bank's JAZZ Position: Q1 2020 in Review

First Hawaiian Bank sold out of Jazz Pharmaceuticals (JAZZ) in Q1 2020, closing a stake of 3,356 shares — an estimated $501K sold.

First Hawaiian Bank first reported a position in JAZZ in Q3 2018 and held it in 6 quarters. The position peaked at $604K in Q2 2019. 407 funds tracked by Wall St. Rank hold JAZZ as of Q1 2020.

First Hawaiian Bank reported no remaining Jazz Pharmaceuticals position as of Q1 2020 after selling out during the quarter.
First Hawaiian Bank sold 3,356 Jazz Pharmaceuticals shares in Q1 2020, an estimated $501K.
First Hawaiian Bank first reported a position in Jazz Pharmaceuticals in Q3 2018 and held it in 6 quarters.
First Hawaiian Bank's Jazz Pharmaceuticals position peaked at $604K in Q2 2019.
407 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q1 2020.

Based on First Hawaiian Bank's 13F filing for Q1 2020, filed 21 Apr 2020.